Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA.
Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA.
Nat Genet. 2021 Sep;53(9):1322-1333. doi: 10.1038/s41588-021-00909-9. Epub 2021 Aug 12.
The functional interpretation of genome-wide association studies (GWAS) is challenging due to the cell-type-dependent influences of genetic variants. Here, we generated comprehensive maps of expression quantitative trait loci (eQTLs) for 659 microdissected human kidney samples and identified cell-type-eQTLs by mapping interactions between cell type abundances and genotypes. By partitioning heritability using stratified linkage disequilibrium score regression to integrate GWAS with single-cell RNA sequencing and single-nucleus assay for transposase-accessible chromatin with high-throughput sequencing data, we prioritized proximal tubules for kidney function and endothelial cells and distal tubule segments for blood pressure pathogenesis. Bayesian colocalization analysis nominated more than 200 genes for kidney function and hypertension. Our study clarifies the mechanism of commonly used antihypertensive and renal-protective drugs and identifies drug repurposing opportunities for kidney disease.
由于遗传变异受细胞类型影响,全基因组关联研究(GWAS)的功能解释具有挑战性。在这里,我们针对 659 个人类肾脏样本的微切割生成了综合表达数量性状基因座(eQTL)图谱,并通过映射细胞类型丰度与基因型之间的相互作用,鉴定出了细胞类型-eQTL。通过使用分层连锁不平衡评分回归对遗传力进行分区,将 GWAS 与单细胞 RNA 测序和用于转座酶可及染色质的高通量测序数据的单核测定相结合,我们优先考虑近端小管用于肾功能,以及内皮细胞和远端小管节用于血压发病机制。贝叶斯共定位分析为肾功能和高血压提名了 200 多个基因。我们的研究阐明了常用降压和肾脏保护药物的作用机制,并确定了肾脏疾病药物再利用的机会。